# CONEXXENCE

NDC: 65219-668
Generic name: Denosumab
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20250630

FDA application: BLA761398

## Active ingredients

- DENOSUMAB: 60 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65219-668"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65219-668
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=39a0a789-778f-4695-b3a9-61643e6396cd